Current management of ovarian carcinosarcoma
- 14 November 2006
- journal article
- review article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 17 (2) , 316-324
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Carcinosarcoma of the ovary—a case seriesGynecologic Oncology, 2006
- Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinomaCancer, 2005
- Chemotherapeutic management of recurrent/metastatic uterine carcinosarcomas (malignant mixed mullerian tumors): time for a re-appraisal?Journal of Cancer Research and Clinical Oncology, 2004
- Circulating angiogenic factor levels correlate with extent of disease and risk of recurrence in patients with soft tissue sarcomaAnnals of Oncology, 2004
- Cytoreductive surgery plus intraperitoneal hyperthermic perfusion is an effective treatment for metastasized malignant mixed mesodermal tumours (MMMT)—report of six casesEuropean Journal of Surgical Oncology, 2004
- Cisplatin as initial chemotherapy in ovarian carcinosarcomas: a Gynecologic Oncology Group studyGynecologic Oncology, 2004
- Determination of vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomas and the role of overexpression in leiomyosarcomaJournal of Cancer Research and Clinical Oncology, 2004
- Malignant mixed mesodermal tumours: biology and clinical aspectsEuropean Journal of Cancer, 2002
- Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?Journal of Clinical Pathology, 2002
- A Phase II Trial of Ifosfamide and Mesna in Patients with Advanced or Recurrent Mixed Mesodermal Tumors of the Ovary Previously Treated with Platinum-Based Chemotherapy: A Gynecologic Oncology Group StudyGynecologic Oncology, 1994